| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.35▼ | 2.35▼ | 2.38▼ | 2.36▼ | 2.27▼ |
| MA10 | 2.35▼ | 2.34▼ | 2.34▼ | 2.34▼ | 2.57▼ |
| MA20 | 2.34▼ | 2.33▼ | 2.33▼ | 2.32▼ | 2.38▼ |
| MA50 | 2.31▼ | 2.42▼ | 2.48▼ | 2.61▼ | 3.23▼ |
| MA100 | 2.55▼ | 2.49▼ | 2.45▼ | 2.39▼ | 4.65▼ |
| MA200 | 2.38▼ | 2.49▼ | 2.61▼ | 3.01▼ | 10.20▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.003▲ | 0.013▲ | 0.012▲ | 0.040▲ |
| RSI | 41.947▼ | 43.328▼ | 43.056▼ | 41.732▼ | 42.488▼ |
| STOCH | 65.278 | 60.714 | 68.067 | 52.088 | 28.456 |
| WILL %R | -100.000▼ | -100.000▼ | -94.737▼ | -78.689▼ | -74.860 |
| CCI | -123.162▼ | -124.961▼ | -116.364▼ | -110.514▼ | -39.197 |
|
Wednesday, May 15, 2024 04:00 PM
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focusing on gene therapies for eye diseases, reported its first-quarter financial results for 2024 and provided an update on its ...
|
|
Wednesday, May 15, 2024 07:34 AM
cell and gene therapies, and mRNA vaccines. Post-transaction, Johannes Kirchmair and Thomas Wurm, co-founders of Single Use Support, will each retain 10% ownership, along with U.S. life sciences ...
|
|
Wednesday, May 15, 2024 05:18 AM
Q1 2024 Earnings Call Transcript May 14, 2024 Operator: Good morning, and welcome to Ocugen’s First Quarter 2024 Financial Results and Business Update. Please note that this call is being recorded. At ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/05/24 | 2.26 | 2.26 | 2.25 | 2.25 | 9,487 |
| 15/05/24 | 2.44 | 2.4451 | 2.25 | 2.43 | 9,852 |
| 14/05/24 | 2.41 | 2.44 | 2.27 | 2.44 | 7,070 |
| 13/05/24 | 2.315 | 2.39 | 2.315 | 2.39 | 9,631 |
| 10/05/24 | 2.31 | 2.38 | 2.21 | 2.29 | 13,462 |
| 09/05/24 | 2.2601 | 2.3501 | 2.21 | 2.29 | 32,630 |
| 08/05/24 | 2.38 | 2.4247 | 2.25 | 2.25 | 24,779 |
| 07/05/24 | 2.34 | 2.4499 | 2.34 | 2.40 | 14,842 |
| 06/05/24 | 2.49 | 2.49 | 2.275 | 2.38 | 34,685 |
| 03/05/24 | 2.35 | 2.3671 | 2.23 | 2.2546 | 27,393 |
|
|
||||
|
|
||||
|
|